INTRODUCTION
============

Induction of three germ layers (ectoderm, mesoderm, and endoderm) and axis formation including the dorsoventral and anteroposterior posterior regions are major events during vertebrate embryo development. Signals from bone morphogenetic protein-4 (BMP-4), fibroblast growth factor (FGF), and Wnt play crucial roles during early embryo development and early patterning ([@b13-molce-39-4-352]; [@b15-molce-39-4-352]; [@b21-molce-39-4-352]; [@b26-molce-39-4-352]; [@b36-molce-39-4-352]).

In *Xenopus*, BMP-4 is expressed in the ventral mesoderm and ectoderm and acts as a ventral morphogen in a direct and long-range fashion to establish its gradient and specific cell fate ([@b6-molce-39-4-352]; [@b47-molce-39-4-352]). When the BMP-4 gradient is established, responding cells activate different genes at distinct threshold levels, resulting in dorsoventral patterning of the mesoderm as well as ectoderm during early *Xenopus* development ([@b19-molce-39-4-352]; [@b22-molce-39-4-352]). If BMP-4 mRNA is injected into *Xenopus* embryos, the dorsal mesoderm is converted into the ventral mesoderm ([@b3-molce-39-4-352]; [@b17-molce-39-4-352]; [@b18-molce-39-4-352]; [@b20-molce-39-4-352]). On the other hand, over-expression of a dominant negative BMP-4 receptor (DNBR) into ventral territories results in the formation of a secondary body axis ([@b11-molce-39-4-352]; [@b40-molce-39-4-352]). BMP-4 is a strong candidate as an epidermal, ventral mesodermal inducer as well as a neural inhibitor ([@b45-molce-39-4-352]). Previously, [@b43-molce-39-4-352] reported that *in-vivo* BMP inhibition triggered at stage 5 not only expands the neural plate but also represses the neural crest marker.

The development of the central nervous system (CNS) begins when the ectoderm gives rise to the neural plate. Early neurogenesis is initiated by inhibition of BMP signaling in the ectoderm by BMP antagonists expressed in Spemann's organizer region, resulting in anterior neural tissue formation ([@b14-molce-39-4-352]). According to a generally accepted mechanism, inhibition of BMP signaling generates anterior neural tissue as a default pathway ([@b31-molce-39-4-352]). Wnts, FGF and retinoic acids (RA) act as modifiers of anterior to posterior neural specification ([@b2-molce-39-4-352]; [@b23-molce-39-4-352]; [@b34-molce-39-4-352]; [@b46-molce-39-4-352]). However, it is unclear whether anterior neural tissue produced by inhibition of BMP is simply generated by a default pathway of pre-existing intracellular molecules or by the newly expressed posterior modifier inhibition molecules.

The intracellular level of active RA is determined by the balance between RA synthesis by retinaldehyde dehydrogenases (RALDHs) and its degradation by *Cyp26* enzymes, the latter of which constitute a group of P450 enzymes that metabolize RA to its inactive forms ([@b7-molce-39-4-352]; [@b33-molce-39-4-352]; [@b44-molce-39-4-352]). *Cyp26* enzymes are thought to play a central role in the appropriate regulation of the RA signal as a posteriorizing factor in CNS development ([@b1-molce-39-4-352]; [@b35-molce-39-4-352]; [@b37-molce-39-4-352]). Mice and humans possess three *Cyp26* genes: *Cyp26a1*, *Cyp26b1* and *Cyp26c1* ([@b28-molce-39-4-352]; [@b30-molce-39-4-352]; [@b41-molce-39-4-352]). *Cyp26* genes have been previously characterized in various species, but their function in *Xenopus leavis* have not yet been fully identified. The role of *Cyp26* during RA utilization and the anteriorization of the neuroectoderm during the early embryonic stages of *Xenopus* is also unclear.

Wnt and FGF are also known as anterior to posterior modifiers during early neurogenesis. *Cyp26* is regulated by both Wnt and FGF signaling ([@b24-molce-39-4-352]; [@b27-molce-39-4-352]). Wnt is reportedly responsible for (A-P) neural patterning, as an injection of a truncated form of BMP receptor into the ventral side of embryos results in the formation of a secondary axis without a head. Inhibition of XWnt8 with dn-XWnt8 induces the formation of a complete axis with a head, indicating that inhibition of Wnt signaling is important for head formation ([@b10-molce-39-4-352]). *xCyp26c* is negatively regulated by Wnt signaling and is different from *xCyp26a. Cyp26c* is expressed in the anterior region, and the expression of *Cyp26c* is positively regulated by inhibition of canonical Wnt signaling and also by a high-dose RA treatment in the neurula ([@b42-molce-39-4-352]).

To examine whether RA metabolism is involved in the anterior neurogenesis caused by the inhibition of BMP, we sought to identify the genes that are regulated during early neurogenesis and anterior neural patterning. The gene expression profiles were analyzed using *Xenopus* Affymetrix gene chips. We found that the RA-degrading enzyme *xCyp26c* was upregulated and the RA-synthesizing enzyme RALDH was downregulated following BMP-4 inhibition with DNBR in *Xenopus* animal cap explants. We found that *xCyp26c* played a critical role in the specification of anterior neural tissue in animal cap explants and whole embryos. In summary, we concluded that *xCyp26c* upregulated by DNBR is required for anterior neural development via RA degradation during early *Xenopus* development. We suggest that anterior neural tissue is not simply generated by a default pathway of pre-existing intracellular molecules but by the posterior modifier inhibition molecules, including *xCyp26c*, which is newly expressed after inhibition of BMP signaling.

MATERIALS AND METHODS
=====================

Embryo injection and explant culture
------------------------------------

*Xenopus leavis* embryos were obtained by artificial fertilization ([@b38-molce-39-4-352]). Developmental stages were determined according to Nieuwkoop and Faber ([@b32-molce-39-4-352]). The vitelline membranes were removed by immersing the embryos in 2.5 % thioglycolic acid. Embryos at the one-cell stage or two-cell stage were injected in the animal pole with messenger RNA, as described in the figure legends. Animal caps were dissected from the injected embryos at stage 8--9 and cultured to various stages in 67% Leibovitz's L-15 medium (GIBCO/BRL) with BSA (1 mg/ml), 7 mM Tris-HCl (pH 7.5) and gentamicin (50 μg/ml).

### *In vitro* transcription

All of the synthetic mRNAs used for microinjection were produced by *in vitro* transcription. The *xCyp26c* cDNA was inserted in the pCS2 vector. The cDNA was linearized and used for in synthesis of capped mRNA using an *in vitro* transcription kit (Ambion) in accordance with the manufacturer's instructions. The synthetic RNA was quantified by ethidium bromide staining in comparison with a standard RNA ([@b48-molce-39-4-352]).

### RNA isolation and reverse transcription-polymerase chain reaction (RT-PCR)

Total RNA was extracted from whole embryos or cultured animal explants with TRIzol reagent (Tel-Test Inc.) following the manufacturer's instruction. RT-PCR was performed with a Superscript preamplification system (Invitrogen). PCR was performed as follows: first, a denaturation step of 94°C for 5 min; second, 94°C for 1 min; third, annealing temperature appropriate for each primer pair for 1 min; fourth, 72°C for 1 min; and fifth, repeat the second, third and fourth steps for 19--30 cycles of amplification as described by the *Xenopus* Molecular Marker Resource (XMMR; University of Texas).

### Morpholino oligos

Morpholino oligos (Gene tools LLC) for antisense oligodeoxynucleotides were used for loss-of-function studies. The base composition of the antisense oligodeoxynucleotide was a 25-mer morpholino 5′ TAC AAG ATG TTC CTC CTT GAG ATC A 3′ (MO-*xCyp26c*). Morpholino oligos substitute riboside moieties with nitrogen-containing morpholine moieties and are phosphorodiamidate-linked ([@b39-molce-39-4-352]). Oligos were re-suspended in sterile water and injected at doses of 40 ng per embryo ([@b49-molce-39-4-352]).

### Whole-mount *in situ* hybridization

Whole-mount *in situ* hybridization was completed as described ([@b12-molce-39-4-352]) with modifications as reported ([@b16-molce-39-4-352]). Embryos were fixed in MEMFA and processed for the whole-mount *in situ* hybridization using digoxigenin-labeled antisense RNA probes. To produce the *xCyp26c* antisense probe, the cDNA was linearized by *Eco*RI and transcribed with T7 RNA polymerase (Ambion).

RESULTS
=======

### *xCyp26c* is induced by BMP inhibition and expressed in an anterior specific pattern in *Xenopus* embryos

To identify the genes involved during early neurogenesis, homogeneous animal cap explant samples were obtained from embryos with or without BMP signaling inhibition. Two nanograms of synthetic mRNA of DNBR was injected into one- or two-cell stage embryos. Animal cap explants isolated from blastula stage (stage 8--9) embryos were allowed to develop until the early gastrula stage (stage 11.5--12). The gene expression profiles were analyzed using *Xenopus* Affymetrix Gene chips containing 14,400 gene transcripts. Expression of various genes during early neurogenesis was induced by BMP signaling inhibition. We found 'Xl.1946.1.A1\_' to be a newly expressed gene in early neuroectodermal cells ([Fig. 1A](#f1-molce-39-4-352){ref-type="fig"}). We isolated the full-length cDNA of this gene and identified it as a member of the *Xenopus* cytochrome P450 subfamily 26c (*xCyp26c*) through homology analysis of amino acid sequences in NCBI protein databases. Alignment of multiple sequences and phylogenetic analysis were used to determine the *Cyp26* subfamilies ([Fig. 1B](#f1-molce-39-4-352){ref-type="fig"}).

Using RT-PCR, we analyzed the temporal expression of *xCyp26c* mRNA throughout embryogenesis ([Fig. 1C](#f1-molce-39-4-352){ref-type="fig"}). Temporal-*xCyp26c* was not expressed maternally, but was detected in the gastrula stages (stage 12), and expression was sustained to the tail bud stage. To examine the spatial expression pattern of *xCyp26c*, we performed whole-mount *in situ* hybridization during the embryonic stages ([Fig. 1D](#f1-molce-39-4-352){ref-type="fig"}). *xCyp26c* shows a restricted expression pattern in the anterior region from the early neural to tail bud stage ([Fig. 1D](#f1-molce-39-4-352){ref-type="fig"}). Zygotic expression of *xCyp26c* was detected as a semi-circular shape during the late gastrula stage in the dorsal region ([Fig. 1D](#f1-molce-39-4-352){ref-type="fig"}) and at a tail-bud stage in the presumptive anterior neural region ([Fig. 1D](#f1-molce-39-4-352){ref-type="fig"}).

### Ectopic expression of *xCyp26c* induces neural genes in animal cap explants

To investigate the function of *xCyp26c* during early *Xenopus* development, gain-of-function experiments were performed. For effective *xCyp26c* expression in *Xenopus* embryos, *xCyp26c* mRNA was injected into one- or two-cell stage embryos. Animal caps were dissected from the injected embryos at stage 8--9 and cultured to stages 12 and 24, as described in the Materials and Methods.

At stage 12, *xCyp26c* induced the expression of the early neural marker *Zic3*, *Ngnr1* ([Fig. 2A](#f2-molce-39-4-352){ref-type="fig"}). However, *xCyp26c* had no effect on the expression of ventral (*Vent1*) or mesodermal markers (*Xbra*). At stage 24, the expression of the anterior neural marker *Otx2* was slightly increased by *xCyp26c* ([Fig. 2B](#f2-molce-39-4-352){ref-type="fig"}). Otherwise, the posterior neural marker *HoxB9* and the mesoderm marker *actin* were not induced by *xCyp26c*. These results provided evidence for a specific role for *xCyp26c* in anterior neural development, but not in mesoderm and posterior formation at the molecular level.

### *xCyp26c* inhibits all-trans and 9-cis RA-induced posteriorization of anterior neural tissue in animal cap explants

To investigate whether *xCyp26c* was involved in A-P patterning, we examined the effect of *xCyp26c* in combination with DNBR and RA (all-trans and 9-cis RA), which induced both anterior and posterior neural tissue in animal cap explants ([@b42-molce-39-4-352]). Animal caps were isolated from embryos injected with *xCyp26c* mRNA or DNBR and cultured in the presence or absence of RA (all-trans and 9-cis RA). RT-PCR analysis showed that *xCyp26c* enhanced anterior neural marker (*Otx2*, *BF1*) and inhibited posterior neural maker expression (*HoxB9*) ([Figs. 3A and 3B](#f3-molce-39-4-352){ref-type="fig"}). However, *xCyp26c* did not affect the expression of the anterior neural marker in A-P patterning induced by a combination of DNBR and basic FGF (bFGF), whereas it enhanced posterior neural markers ([Fig. 3C](#f3-molce-39-4-352){ref-type="fig"}). As results, we suggest that *xCyp26c* blocks the posteriorization caused by RA, but not by bFGF.

### Depletion of *xCyp26c* inhibits the formation of normal axis and head structures in whole embryos

To further verify the function of *xCyp26c* during normal development, we performed a loss-of-function study using the anti-sense morpholino directed against *xCyp26c* (MO-*xCyp26c)*. We generated a MO-*xCyp26c* that targets the first 25 nucleotides of the untranslated region, including the AUG translational start site in *Xenopus xCyp26c* mRNA. MO-*xCyp26c* was effective in specifically reducing the level of the 3′-terminal end HA-or Flag-tagged *xCyp26c* protein (*xCyp26c*-HA-or *xCyp26c*-flag) ([Fig. 4A](#f4-molce-39-4-352){ref-type="fig"}). Injection of MO-*xCyp26c* into the animal region at the one- or two-cell stage caused inhibition of axis formation and the head structure of tadpole stage embryos ([Fig. 4B](#f4-molce-39-4-352){ref-type="fig"}).

To investigate whether depletion of *xCyp26c* could inhibit DNBR-induced anterior neural marker expression, animal caps isolated from embryos injected with MO-*xCyp26c* alone or together with DNBR were incubated until stage 24. MO-*xCyp26c* did not suppress the expression of *Otx2* induced by DNBR ([Fig 4C](#f4-molce-39-4-352){ref-type="fig"}).

DISCUSSION
==========

In this study, we examined whether RA metabolism was involved in the anterior neurogenesis caused by the inhibition of BMP. We found that the RA-degrading enzyme *xCyp26c* was upregulated and that the RA-synthesizing enzyme RALDH was downregulated after BMP signaling blockade in animal cap explants from *Xenopus* embryos. We also observed that ectopic expression of *xCyp26c* induced neural gene expression and inhibited all-trans and 9-cis RA-induced posteriorization of neural tissue in animal cap explants. In addition, depletion of *xCyp26c* inhibited the formation of normal axis and head structures in whole embryos. Taken together, *xCyp26c* upregulation by DNBR is necessary for anterior neural development in *Xenopus*. We suggest that anterior neurogenesis may not be the default pathway for pre-existing intracellular molecules, but requires newly synthesized posterior modifier inhibitors, including *xCyp26c*, after inhibition of BMP signaling.

We examined whether the inhibition of BMP directly elicited anterior neurogenesis without the involvement of RA metabolism or with RA-metabolizing enzymes, which were newly up-regulated after BMP signaling blockade. To identify the genes involved in early neurogenesis, we used a *Xenopus* Affymetrix gene chip containing 14400 gene transcripts and obtained 107 ESTs that was upregulated after inhibition of BMP signaling. Among these ESTs, we found that *X1.19461A1*-at was upregulated. This was further characterized as a member the *Xenopus* cytochrome P450 subfamily 26, *xCyp26c*, which is a metabolic enzyme that converts active RA to its inactive form. In this study, we found that BMP inhibition upregulated the expression of the RA degradation enzyme *xCyp26c* and downregulated the RA-synthesizing enzyme RALDH during neurogenesis in animal cap explants. A-P neural patterning plays a key role in the formation of normal neural development in embryos. Antagonists of Wnt or BMPs are expressed as anteriorizing factors ([@b8-molce-39-4-352]), whereas Wnts induce neuroectoderm posteriorization in *Xenopus* ([@b25-molce-39-4-352]). Other signaling molecules, such as FGFs and RA, are also involved in embryonic A-P specification as modifiers ([@b5-molce-39-4-352]; [@b9-molce-39-4-352]; [@b29-molce-39-4-352]). Previously, it has been reported that *xCyp26c* is expressed in the anterior region during early neural development ([@b16-molce-39-4-352]). Its expression is specifically restricted to the anterior neural region during the early neurula to tailbud stages. We also found that *xCyp26c* is not expressed maternally. Most importantly, components of RA signaling, RA receptor, and RA converting enzyme (RALDH), which are expressed in dorsolateral ectoderm and more posteriorly, lead to a reduction in anterior structures and induction of positional genes ([@b8-molce-39-4-352]). Alternatively, RA hydroxylase (*Cyp26*), which targets RA for degradation, leads to the expansion of anterior structures ([@b4-molce-39-4-352]; [@b16-molce-39-4-352]). To examine the expression profiles of posterior modifier modulating genes in early neurogenesis (stage 11), we analyzed 98 genes that were the most upregulated by BMP inhibition in animal cap explants. At least, 3 genes were RA-related enzymes, and 4 genes were Wnt signal related molecules, including secreted frizzled protein 2, frizzled 4 and 7. In fact, *xCyp26c* has been reported as one of the genes that are negatively regulated by canonical Wnt signaling through the anterior neuroectoderm of early neural embryos ([@b42-molce-39-4-352]). A more detailed study of the relationship between Wnt and RA and their mutual regulation mechanisms during anterior neurogenesis is needed. We suggest that anterior neurogenesis caused by BMP inhibition may not be the default pathway of pre-existing molecules but may require the expression of new molecules that inhibit anterior to posterior modifier molecules such as RA and Wnt.

In this study, we found that *xCyp26c* was expressed during the late gastrula stage, and the expression remained higher in later developmental stages. Whole-mount *in situ* hybridization revealed that it is anteriorly expressed, similar to previous reports that also mentioned that temporal expression of *xCyp26c* in the anterior embryonic region was 40-fold higher than in the posterior region. *xCyp26c* is expressed in only a subset of cranial nerves during late embryonic development ([@b42-molce-39-4-352]). Because inhibition of BMP with DNBR upregulated the expression *xCyp26c* in animal explants, we examined the roles of *xCyp26c* in neurogenesis. We found that overexpression of *xCyp26c* upregulated the expression of neural markers zic3, otx2, and ngnr1 in animal explants. However, the expression of ventral markers vent-1, vent-2, GATA-2, xbra and actin (mesodermal marker) were not affected much. It is interesting how the overexpression of the RA degradation enzyme *xCyp26c* led to the upregulation of neural genes, including zic3, otx2 and ngnr1. The neurogenesis mechanism caused by *xCyp26c* remains unclear.

Previously, [@b23-molce-39-4-352] reported that the *Cyp26* enzyme utilizes RA as its main substrate within an expected range to a limit of RA-mediated posteriorization of embryos. *Cyp26* plays a crucial role in the A-P patterning of the neural ectoderm in the late blastula stage, whereas Hoxb1 is expressed later as an earlier posterior marker ([@b24-molce-39-4-352]). FGF signaling is also involved in posterior neural formation ([@b46-molce-39-4-352]). We examined whether *xCyp26c* was specific for A-P patterning including RA or is also involved in FGF-mediated patterning. *xCyp26c* was specifically involved in A-P patterning by blocking the posteriorization caused by RA, but did not affect the posteriorization induced by FGF. The results showed that *xCyp26c* induced anterior neural marker (otx2 and BF1) and inhibited posterior marker expression (HoxB9), but did not affect the expression of anterior neural markers in A-P patterning in the presence of FGF and DNBR. Rather, *xCyp26c* upregulated the posterior neural marker expression ([Fig. 3c](#f3-molce-39-4-352){ref-type="fig"}). In a previous report in *zebrafish* embryos ([@b24-molce-39-4-352]), FGF3 and Wnt signaling were reported to independently suppress *Cyp26*, and FGF or Wnt signals initiate posterior gene expression only in the presence of an intact RA signaling pathway. Because FGF over-activation may lead to an expansion of posterior genes more than that due to abrogation of Cyp26, FGF-mediated posteriorization may include other factors and/or different FGFs may use a different set of RA-metabolizing enzymes. Wnt facilitates the A-P patterning and requires Cyp26c mediated RA metabolism ([@b42-molce-39-4-352]). In our study, the results indicated that bFGF mediated A-P patterning was not fully dependent on RA metabolism by *xCyp26c*.

We also found that the loss of function assay of *xCyp26c* by using *Mo-xCypc26* led to anterior truncation in whole embryos. However, DNBR-induced anterior neural tissue was not suppressed by the depletion of *xCyp26c* in animal cap explants. These results indicate that *xCyp26c* is not an essential factor for anterior neurogenesis caused by BMP inhibition. Instead, we suggest that other factors, such as Wnt signal inhibitors, must contribute to the anterior neurogenesis in animal cap explants. Taken together, all of these results proved our proposed hypothesis that *xCyp26c* is involved in anterior neural tissue development during early embryonic stages of *Xenopus leavis*. However, the detailed interaction mechanism among FGF, Wnt and RA signals in neurogenesis and the mechanism for anterior neurogenesis by BMP inhibition require further study.
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![Induction of *xCyp26c* by blocking BMP in animal cap explants and the expression pattern of *xCyp26c* in whole embryos. (A) Selection of the 'Xl.1946.1.A1_at' gene induced by DNBR in a cDNA microarray. The expression of 'Xl.1946.1.A1_at' was confirmed by RT-PCR. (B) Phylogenetic relationships among the *xCYP26* proteins. (C) Developmental expression of *xCyp26c.* RT-PCR analysis was performed at various stages, as indicated ([@b32-molce-39-4-352]). Histone 4 or *EF1α* serve as an RNA loading control. (D) Spatial expression patterns of *xCyp26c.* Whole-mount *in situ* hybridization analysis of *xCyp26c* was performed during oocyte to tail bud stages. Views of whole embryos at the stages are indicated on top of each column. *xCyp26c* was expressed in the presumptive anterior neural ectoderm, and the expression continued to the tail bud stage.](molce-39-4-352f1){#f1-molce-39-4-352}

![Induction of neural genes by overexpression of *xCyp26c* in animal cap explants. *Xenopus* embryos at the one cell stage or two-cell stage were injected in the animal pole with *xCyp26c* mRNA. Animal caps were dissected from the injected embryos at stages 8--9 and cultured to stage 12 (A) or 24 (B). RT-PCR was then performed to detect expression of the indicated genes. *EF1α* serves as a RNA loading control.](molce-39-4-352f2){#f2-molce-39-4-352}

![Inhibition of all-trans and 9-cis retinoic acid-induced posteriorization by overexpression of *xCyp26c* in animal cap explants. *xCyp26c* was injected with DNBR, and animal caps were treated with all-trans retinoic acid (AT-RA) (A), 9-cis retinoic acid (9cRA) (B), and basic FGF (bFGF) (C) at stage 8 and then cultured to stage 24. The expression pattern of marker genes were analyzed by RT-PCR.](molce-39-4-352f3){#f3-molce-39-4-352}

![Inhibition of normal head and axis formation by depletion of endogenous *xCyp26c*. Morpholino activity was confirmed by Western blot. (B) Embryos injected with 40 ng of MO-*xCyp26c* did not have head structures and had short axis formation. (C) *xCyp26c* was injected with DNBR and animal caps were cultured to stage 24. Expression patterns of *Otx2* and *HoxB9* were analyzed by RT-PCR.](molce-39-4-352f4){#f4-molce-39-4-352}
